CareDx reports results for quarter ended Sept. 30, 2025

CareDx, Inc. filed a current report to furnish a press release announcing its financial results for the quarter ended September 30, 2025.

Rhea-AI Filing Summary

CareDx, Inc. filed a current report to furnish a press release announcing its financial results for the quarter ended September 30, 2025. The company issued the press release on November 4, 2025 and attached it as Exhibit 99.1.

The information about these quarterly results is being furnished under the rules for results of operations and Regulation FD disclosure, and is expressly stated not to be treated as filed for liability purposes or automatically incorporated into other securities law filings. CareDx also notes that the press release is current as of November 4, 2025 and that it does not undertake to update this material.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CareDx (CDNA) disclose in this 8-K filing?

CareDx furnished a press release announcing its financial results for the quarter ended September 30, 2025, which is attached as Exhibit 99.1.

When did CareDx announce financial results for the quarter ended September 30, 2025?

CareDx announced its financial results in a press release dated November 4, 2025 and furnished that release in this report.

Where can investors find the details of CareDxs September 30, 2025 quarter results?

The detailed results are contained in the press release attached as Exhibit 99.1 to this report, which the company also intends to post on its website.

Is the CareDx November 4, 2025 press release considered filed with the SEC?

No. The company states that the information in Item 2.02, including Exhibit 99.1, is furnished and not deemed filed for purposes of Section 18 of the Exchange Act.

What exhibits did CareDx include with this 8-K for its September 30, 2025 quarter?

CareDx included Exhibit 99.1, the press release dated November 4, 2025, and Exhibit 104, the cover page interactive data file in Inline XBRL format.

Who signed the CareDx 8-K related to the September 30, 2025 quarter results?

The report was signed on behalf of CareDx, Inc. by Nathan Smith, Chief Financial Officer and Principal Accounting and Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/04/2025 - 04:09 PM Learn about SEC filing dates

0001217234FALSE00012172342025-11-042025-11-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 4, 2025

CAREDX, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware

001-36536

94-3316839

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

8000 Marina Boulevard, 4th Floor

Brisbane, California 94005

(Address of Principal Executive Offices) (Zip Code)

(415) 287-2300

Registrant’s telephone number, including area code

N/A

(Former Name, or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 Securities registered pursuant to Section 12(b) of the Exchange Act:

(Title of each class)

(Trading Symbol)

(Name of exchange on which registered)

Common Stock, $0.001 Par Value

CDNA

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On November 4, 2025, CareDx, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this Item 2.02, including the press release attached hereto as Exhibit 99.1, is intended to be furnished under Item 2.02 and Item 9.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such a filing.

Item 7.01. Regulation FD Disclosure.

The Company is furnishing a press release, attached as Exhibit 99.1 to this Current Report on Form 8-K (the “Press Release”), which the Company intends to post on the Company’s website. The Press Release is current as of November 4, 2025, and the Company disclaims any obligation to update this material in the future.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.						Description
99.1						Press Release issued by CareDx, Inc., dated November 4, 2025.
104						Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 4, 2025			CAREDX, INC.
			By:			/s/ NATHAN SMITH
						Nathan Smith
						Chief Financial Officer
						(Principal Accounting and Financial Officer)